Prostate Cancer International is
for 2011 by Great NonProfits
In a new paper just published on-line in the Journal of Urology, Kapoor et al. have provided data on trends in the utilization of various major types of treatment for the management of localized prostate cancer among Medicare beneficiaries in the USA between 2006 and 2008.
Filed under: Management, Treatment | Tagged: beneficiary, cryotherapy, Medicare, radiation, surgery, Treatment, utilization | Leave a Comment »
The addition of androgen deprivation therapy (ADT) to radiation therapy for men with localized prostate cancer is common. It may be used to reduce the size of the prostate prior to brachytherapy or for longer periods in men with higher risk disease to extend survival (which has been demonstrated in large-scale, randomized, multi-center clinical trials).
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ADT, androgen deprivation therapy, brachytherapy, cardiovascular disease, history, mortality, radiation, risk | 4 Comments »
Prostate cancer patients are commonly concerned about the potential risks for side effects associated with adjuvant and salvage radiation therapy after a preceding, first-line, radical prostatectomy.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: IMRT, intensity-modulated, prostate bed, radiation, side effect, toxicity, whole pelvis | 2 Comments »
An updated, systematic review just published in Annals of Internal Medicine states that it is impossible to come to any conclusions about the efficacy of radiation therapy compared with active surveillance or watchful waiting for the management of localized prostate cancer because of the absence of any high-quality, comparative data.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: benefit, comparative, localized, outcome, radiation | Leave a Comment »
A recent study published in “The Red Journal” suggests (perhaps not surprisingly) that radiation oncologists and urologists have different mindsets about the application of immediate adjuvant radiation therapy following surgery for prostate cancer patients with a variety of adverse pathologic risk factors.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, radiation, salvage, second-line | 7 Comments »
Knowledge of the effectiveness and safety of radical prostatectomy as salvage treatment for men with biochemical recurrence after first-line radiation therapy has long been hampered by the fact that most data are based on small series of patients from individual institutions.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: outcome, radiation, radical prostatectomy, salvage, surgery | 1 Comment »
According to an article by Hirsch et al. in the inaugural issue of Practical Radiation Oncology (a new journal for radiation oncologists and their staff), there are some small but significant post-operative differences in pelvic anatomy between patients who undergo robot-assisted laparoscopic prostatectomy (RALP) as opposed to standard, open forms of radical prostatectomy.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: laparoscopic, planning, radiation, radical prostatectomy, RALP, robot, Treatment | 2 Comments »
A new article in Lancet Oncology has reported that a mere 6 months of neoadjuvant hormone therapy, when combined with radiation therapy, cuts the risk of dying from locally advanced prostate cancer by 50 percent compared to radiation alone at 10 years of follow-up.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation, hormone, neoadjuvant, outcome, radiation, survival | 12 Comments »
We really have no idea what the “best” way is to treat men with progressive disease after first-line radiation therapy.
Filed under: Uncategorized | Tagged: cryotherapy, outcome, progression, radiation, salvage | 3 Comments »
RTOG 96-01 is a randomized, multi-center Phase III trial designed to compare bicalutamide monotherapy + salvage radiation therapy to a placebo + salvage radiation alone in men with pT2-3N0Mo prostate cancer who have an elevated PSA after surgery.
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: bicalutamide, outcome, radiation, RTOG 96-01, salvage | 2 Comments »
Long-term follow-up data have just been published from two studies designed to provide preliminary information on the potential use of very aggressive forms of treatment in men with high-risk categories of prostate cancer.
Filed under: Management, Treatment | Tagged: aggressive, androgen deprivation, docetaxel, hormone, paclitaxel, radiation, taxane, therapy | 7 Comments »
There is a recognized risk for development of secondary primary cancers (SPCs) after first-line treatment with radiation therapy for localized prostate cancer. However, a new article suggests that newer forms of radiation therapy may have noticeably reduced that risk.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cancer, outcome, radiation, secondary | 6 Comments »
A new article on the WebMD web site appears under the heading “Targeted radiation may help men avoid impotence,” but it is the incidence of adverse genitourinary (GU) obstructive symptoms during and after treatment that is of greater interest to The “New” Prostate Cancer InfoLink.
Filed under: Management, Treatment | Tagged: adverse effect, erectile function, genitourinary, obstructive, ouctome, PBRT, proton beam, radiation | 5 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site